论文部分内容阅读
目的 探讨连续性肾脏替代治疗 (CRRT)技术及连续性肾替代治疗床边机ADM0 8TM ABMTM 在重症急性肾功能衰竭 (SARF)救治中的应用和对预后的影响。方法 :回顾分析 1999年 3月～ 2 0 0 1年 6月用连续性肾替代治疗床边机ADM0 8TM ABMTM的连续性静脉 -静脉血液滤过 (CVVH)模式治疗 18例SARF。结果 4例患者因放弃抢救而中断 ,5例因原发病加重而不治 ,9例患者经过每日行CVVH治疗 ,平均 1周左右肾功能好转恢复 ,使用ADM0 8TM ABMTM的CVVH模式治疗过程均能保持血液动力学处于稳定状态 ,全部顺利完成治疗目标。结论 CRRT是SARF的首选疗法 ,使用ADM0 8TM ABMTM的CVVH模式治疗SARF ,患者获得一种安全平稳进行血液净化机会 ,使原发病有可逆性的患者救治成功率提高。
Objective To investigate the application of continuous renal replacement therapy (CRRT) and continuous renal replacement bedside machine ADM0 8TM ABMTM in the treatment of severe acute renal failure (SARF) and its prognostic impact. Methods: A retrospective analysis of 18 cases of SARF treated with continuous veno-venous hemofiltration (CVVH) with continuous renal replacement ADM-8TM ABMTM from March 1999 to June 2011 was performed. Results Four patients were discontinued by giving up resuscitation. Five patients died of exacerbation of the primary disease. Nine patients underwent daily CVVH treatment and their renal function recovered after an average of one week. CVVH treatment with ADM0 8TM ABMTM maintained blood Kinetics in a stable state, all the successful completion of treatment goals. Conclusion CRRT is the first choice of SARF therapy. The CVVH mode of ADM0 8TM ABMTM is used to treat patients with SARF. The patients get a safe and steady chance of blood purification, which improves the success rate of patients with reversible primary disease.